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Reactions of Hemoglobin with
Phenyihydrazine: A Review of Selected
Aspects
by Martin D. Shetlar*t and H. Allen 0. Hill*
It is well known that phenylhydrazine induces hemolytic anemia. This is thought to result from the
reaction of phenylhydrazine with hemoglobin. The accompanying oxidation of phenylhydrazine leads to
the formation of a number of products, including benzene, nitrogen, hydrogen peroxide, superoxide anion
and the phenyl radical. The products formed depend critically on the conditions of the experiment, es-
pecially the amount of oxygen present. It is now known that oxyhemoglobin and myoglobin react with
phenylhydrazine to yield a derivative of hemoglobin containing N-phenylprotoporphyrin in which the
heme group is modified. The recent identification of cr-phenyliron(III) porphyrins in phenylhydrazine-
modified metmyoglobin has aided elucidation of the mechanism of hemoglobin modification. Mechanistic
schemes are proposed to account for product formation.
Introduction
A number of hemolytic agents are known that induce
nonindigenous redox processes in erythrocytes. These
drugs, by reducing the life span of red blood cells below
that deemed normal (about 120 days), can lower the
circulating red blood cell population in susceptible in-
dividuals. Presumably, drug-mediated processes cause
a large enough change in certain properties of a signif-
icant number of red blood cells, e.g., membrane de-
formability (1), that they are removed from circulation
by the spleen and liver and then hemolyzed. Persons
with genetic deficiences in key enzymes involved in red
cell metabolism (e.g., glucose-6-phosphate dehydrogen-
ase, glutathione reductase, glutathione peroxidase) are
particularly susceptible to induction of hemolytic ane-
mia by these redox drugs. Such enzymes are important
components of biochemical pathways that maintain
hemoglobin in its functional reduced state and help avoid
or repair the effects of redox processes that challenge
the integrity of the erythrocyte. General reviews of
drug-induced hemolytic anemias, including their clinical
and genetic aspects, have been given in the literature
(2-4).
Phenylhydrazine (PHZ), a particularly potent redox-
active drug, can induce hemolytic anemia, even in in-
dividuals without erthrocytic enzyme deficiencies (2).
Indeed, the ability of PHZ to cause removal of eriyth-
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rocytes from circulation was the basis of its former use
as a therapeutic agent for polycythemia vera, a disorder
in which increased red cell mass in the circulatory sys-
tem is one symptom (5,6). This potency, as a hemolytic
agent, likewise accounts for the use ofPHZ in producing
experimental anemia in test animals (7).
Observations in the last century indicated that PHZ
could induce dramatic changes in erythrocytes in vitro,
as well as in vivo. Hoppe-Seyler (8) found, in 1885, that
blood from rabbits treated with PHZ was brown in color
and that addition of PHZ to suspended erythrocytes
gave them also a brown coloration; spectroscopic studies
indicated that oxyhemoglobin (HbO2) had disappeared.
In 1890 Heinz (9) likewise found that mixing either nu-
cleated (from cold blooded animals) or nonnucleated
erythrocytes with PHZ turned them green-brown. He
also discovered that inclusion bodies (now termed Heinz
bodies) were formed in erythrocytes exposed to PHZ
and that a number ofcompounds closely related to PHZ,
e.g., N-acetylphenylhydrazine (APHZ), could induce
similar effects. Since these initial observations a large
amount of research effort has been devoted to trying to
understand the processes that occur in erythrocytes, or
with oxyhemoglobin, on exposure to PHZ and related
compounds and how PHZ-induced changes in erythro-
cytes lead to hemolytic anemia. As a result the cellular
and chemical responses of the red blood cell to this agent
have been quite thoroughly scrutinized. It has been
found, for example, that lipid peroxidation occurs within
the cellular membranes of erythrocytes (10) and that
protein-protein crosslinking occurs within the support-
ing network associated with the membrane (11). Oxy-
hemoglobin forms methemoglobin (MHb) by PHZ-in-
SHETLAR AND HILL
duced processes and the reduction of MHb to deoxy-
hemoglobin (Hb) (in anaerobic systems) or the formation
of HbO2 (in aerobic environments) can also be induced
to occur. These reactions of hemoglobin, promoted by
PHZ, do not proceed without accompanying irreversible
degradative reactions. Hemoglobin, whether free in so-
lution or within erythrocytes, reacts with PHZ to yield
"green hemoglobin", a form in which the heme group is
modified (12). Processes induced by PHZ also cause des-
tabilization of the globin portion of hemoglobin, leading
to denaturation and precipitation (12). A number of
small molecules have been experimentally detected as
products of the reaction of hemoglobin with PHZ, some
of them presumably acting as intermediates in inducing
the irreversible products described above. This group
of compounds includes benzene (12), nitrogen (13), hy-
drogen peroxide (14), superoxide anion (15), and the
phenyl radical (16). Other species are suspected ofbeing
involved in the reaction of hemoglobin with PHZ, in-
cluding phenyldiazene (12), phenylhydrazyl (17), and
phenyldiazenyl radicals (18), and the benzenediazonium
ion (1 7).
The catalog of chemical, macromolecular and cellular
effects of PHZ on erythrocytes and hemoglobin, given
above, provides a wealth ofphenomena for any proposed
chemical mechanism(s) for PHZ action to explain. Until
recently, however, progress towards understanding
how PHZ acts has been hindered by the lack of such
basic knowledge as the nature of the modified heme of
green hemoglobin in PHZ treated systems and the stoi-
chiometric relationships between PHZ and oxygen con-
sumption and product formation. This information has
recently become available. Consequently the time ap-
pears ripe to assess our knowledge of the chemical
mechanisms by which PHZ, and certain related com-
pounds, interact with hemoglobin.
Reaction of Hemoglobin with
Phenylhydrazine: Products
In this section we will discuss the chemical products
observed when three forms of hemoglobin (oxyhemo-
globin, deoxyhemoglobin, and methemoglobin) are
treated with phenylhydrazine. In the first subsection
we will focus on the interaction of PHZ with Hb and
MHb in the absence of oxygen. The material presented
in this section will lay the basis for an appreciation of
the importance of oxygen and hydrogen peroxide in the
more complex chemistry occurring in the biologically
relevant reactions of hemoglobin under aerobic condi-
tions.
Deoxyhemoglobin- and Methemoglobin-
Phenylhydrazine Systems in the Absence
of Oxygen
TheHb-PHZ System. Several lines of evidence in-
dicate that Hb does not interact chemically with PHZ.
Certain products, formed in the reaction of PHZ with
hemoglobin in other states, are not found. Beaven and
White (12) noted that benzene is not formed when PHZ
is added to Hb under nitrogen, while Ortiz de Montel-
lano and Kunze (19), under similar conditions, showed
that the chromophore of green hemoglobin was not
found as a product in the Hb-PHZ system, after aerobic
workup with acidified methanol. This latter substance
is formed in the HbO2-PHZ system. Rostorfer and Tot-
ter (20) provided another piece of evidence that reaction
with PHZ does not occur in the Hb-PHZ system. They
reduced MHb anaerobically (see below) and found 2
moles of PHZ were needed to reduce 1 mole of MHb to
Hb. Addition of excess PHZ did not lead to increased
consumption of PHZ, over that required to complete
the reduction.
A mode of interaction, not necessarily leading to de-
composition of phenylhydrazine and covalent modifica-
tion of hemoglobin, would be for PHZ and Hb to form
a reversible heme-Fe"-PHZ complex. Evidence has
not yet appeared to support this idea. If such a complex
is formed, then the PHZ must be assumed to exert a
weak perturbation on the heme as Itano and Robinson
(21) noted that the absorption spectrum of Hb was un-
altered by the presence of PHZ. Studying the related
deoxymyoglobin (Mb)-methylhydrazine (MHZ) sys-
tem, Mansuy et al. (22) noted that MHZ did not bind
to Mb Fe".
TheMHb-PHZSystem. Using results from gas vol-
umetric and spectroscopic experiments, Rostorfer and
Totter (20) concluded that benzene and nitrogen were
formed in equimolar amounts as final products in the
reduction ofMHb with PHZ under anaerobic conditions.
Based on studies of the uptake of carbon monoxide dur-
ing the reaction, they also determined that Hb was
being produced concurrently with benzene and N2. The
same workers also established that two moles of PHZ
were consumed per mole of MHb (4 moles of Fe"',)
reduced. Excess PHZ, over that required for stoichio-
metric purposes, did not cause additional reaction to
occur and could be quantitatively accounted for as PHZ
when the reaction was terminated.
The stoichiometric results, described above, require
that PHZ itself be involved in reduction of only half of
the Fe"' in MHb; the remaining reduction is presum-
ably carried out by one of its oxidation products. The
phenylhydrazyl radical (PHZR) and phenyldiazene
(PDA) are the two most likely candidates. Several con-
siderations favor PHZR as the actual (or at least dom-
inant) reductant of the remaining half of the heme in
MHb. One electron oxidation of PHZ by Fe"', to form
Fe", requires that PHZR be produced as a product,
which in turn must transfer a hydrogen atom or another
electron to an acceptor to form PDA. If PDA is pos-
tulated to be the actual reductant, then one must ac-
count for the disposition of the hydrogen atom or elec-
trons lost in converting PHZR to PDA. While it is
conceivable that the globin or porphyrin portions of
hemoglobin could act as hydrogen atom or electron ac-
ceptors for PHZR, experimental evidence is lacking.
Secondly, Itano and Mannen (23) have shown that re-
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action ofMHb with PDA, under N2, gives both Hb and
a substantial amount of a stable ferrihemochrome. How-
ever, the studies of Rostorfer and Totter (20) indicate
essentially complete conversion of MHb to Hb and of
the PHZ consumed to nitrogen and benzene, while Au-
gusto et al. (24) and Itano and Matteson (25) did not
observe formation of ferrihemochrome in spectropho-
tometric studies ofthe reduction ofMHb by excess PHZ
under argon (24), nitrogen (25), and carbon monoxide
(25). Finally, Itano and Mannen (23) found that incu-
bation of MHb in a mixture containing both PHZ and
PDA under nitrogen, followed by extraction of the re-
sultant ferrihemochrome under air, gave a product in
which about one phenyl per heme was incorporated. On
the other hand, Augusto et al. (24) showed that workup
of the MHb-PHZ system, reacted under argon, with
aerated acidified methanol gave no phenyl-heme ad-
duct. While the incubation and workup conditions were
not strictly comparable, the constrasting results sug-
gest that PDA reacts with MHb to give products other
than just Hb. This is contrary to the results actually
observed in the MHb-PHZ system.
In view of the preceding evidence, it appears that a
reasonable description of the reduction of MHb by PHZ
in the absence of oxygen is given by Eqs. (1).
-MHb + 2 PHZ- Hb + 2PHZR + 2H+2 2
2MHb + 2PHZR -2Hb + 2PDA + 2H+2 ~~~~2
MHb + 2 PHZ -Hb + 2 PDA + 4 H+ (1)
Why then are benzene and nitrogen observed as final
products in the reduction of MHb with PHZ? This can
be accounted for by the observation that PDA readily
undergoes base catalyzed decomposition to give ben-
zene and N2 (18). For example, if OH- is the base, then
the reaction (2) could occur.
PN=NH + OH - PN=N- + H20 (P = phenyl)
PN=N- +P- + N2
P- + H20-+PH + OH-
PN=NH - PH + N2 (2)
This leads to an overall reaction stoichiometry of:
MHb + 2PHZ -* Hb + 2PH + 2N2 + 4H+
as is experimentally observed (20).
The reduction of MHb by PHZ in the absence of oxy-
gen is a reaction that takes place on the time scale of
an hour or so. For example, Augusto et al. (24) noted
that 40 min was required to reduce 46% of the initial
MHb concentration to Hb when 0.02mM MHb was in-
cubated with 0.25mM PHZ under argon. Similarly Ros-
torfer and Totter (20), using higher concentrations of
reactants (0.95 mM MHb, 2.3 mM PHZ), found that 30
min sufficed to reduce 72% of the MHb initially present.
The rate constant for the reduction under argon has
been determined to be 0.33 L/mole-sec at pH 7.4 (26).
(Rostorfer and Totter (20) determined a value of 0.155
L/mole-sec for this constant, but their pH was unspec-
ified.) The reduction of MHb to Hb by PHZ under an-
aerobic conditions is much slower than the reaction of
MHb with PHZ under air to consume oxygen or give
heme adducts. The rate constant for these latter reac-
tions may be estimated to be about 99 and 16.5 L/mole-
sec, by using the data of Augusto et al. (24) on initial
rate of oxygen consumption for the HbO2-PHZ and
MHb-PHZ systems, along with their rate constant for
02 consumption in the HbO2 system, and by assuming
that 6 oxygen molecules are consumed per heme con-
verted to adduct by PHZ. Thus the rate constants for
oxygen consumption and conversion of MHb to heme
adduct in the MHb-PHZ system are about 300 and 50
times larger, respectively, than the rate constant for
reduction of MHb in the absence of 02.
Reaction of HbO2 and MHb with PHZ in
the Presence of 02
Heme Oxidation and Reduction. Heinz, in 1890,
discovered (9) that the reaction of PHZ with HbO2 pro-
duces MHb. He observed that spectroscopic bands cor-
responding to MHb could be observed in suspensions of
erythrocytes treated with PHZ. Since then the pro-
duction of MHb in HbO2-PHZ systems has been often
noted.
The amount of MHb present in a given reacting HbO2
system appears to depend strongly on the ratio of initial
PHZ concentration to initial HbO2 concentration (P/H
ratio), as well as, in a complex manner, on the time of
observation after initiation of the reactions. The P/H
ratio dependence was demonstrated by both Harley and
Mauer (27) and Jandl et al. (28). Using intact erythro-
cytes, Harley and Mauer showed that as the P/H ratio
increased from 0.25 to 2, the amount of MHb observed
after 30 min reaction increased from about 2% to 33%.
On increasing the period of observation from 30 min to
4 hr, however, the sample with P/H = 1 had increased
from about 22% MHb to about 44%, while the sample
with P/H = 2 had decreased slightly from 33% to 30%.
Jandl et al. (18) also examined the effect of P/H ratio
on the amount of MHb present after 2 hr incubation of
HbO2 (containing about 10% MHb) with PHZ. Increas-
ing the P/H ratio from 0 to 40 resulted in a decrease in
the HbO2 concentration from 90% to 10%; however the
MHb increased to reach a maximum of about 37% when
P/H = 4 and then decreased to become insignificant
when P/H = 40. The results of other more limited ex-
periments, indicating that the amount of MHb present
in a HbO2-PHZ system after a particular time depends
on the P/H ratio, have been reported by Rostorfer and
Cormier (29).
A kinetic study was also done by Jandl et al. (28),
using a system in which P/H = 20. In this system the
MHb amounted to about 33% of the initial Hb concen-
tration after one minute of reaction; this quantity de-
creased, at first rapidly and then more slowly, until after
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one hour it became negligible. The amount ofMHb then
gradually rose over the next eleven hours to reach a
value of 9%. The rapid increase and decrease in MHb,
observed in this study, demonstrates that failure to ob-
serve substantial amounts of MHb in a HbO2-PHZ re-
action after a given period of time (in this case 1 hr)
does not necessarily mean that it has not been a major
component of the reaction mixture over some time pe-
riod during its course. Castro et al. (26) reached a sim-
ilar conclusion in experiments in which they reacted
HbO2 with PHZ in a vessel in which the overlying at-
mosphere was argon. They did not observe MHb for-
mation and it appeared that HbO2 was reduced directly
to Hb. However, using excess cyanide to trap MHb,
they found that MHbCN could be observed as the only
product. The rate constants describing formation of Hb
and MHbCN were identical and they concluded that the
formation of MHb by PHZ was the rate determining
step in the PHZ-induced reaction sequence (3):
HbO2 -. MHb -+ Hb (3)
They suggested that oxidation products of PHZ, rather
than PHZ itself, were able to react rapidly with MHb
in the absence of cyanide to reduce it back to the Fe"
state; in the presence of CN- this reaction was not
competitive. Quantitative measurements support the
idea that reaction of MHb itself with PHZ is not the
process leading to reduction of MHb to Hb. The rate
constant for reduction of MHb to Hb by PHZ under
argon was determined to be 0.33 L/mole-sec, but the
rate constant describing the conversion of HbO2 to Hb
via MHb was determined to be 45 L/mole-sec (26). Thus
if PHZ was reducing MHb to Hb, then the rate deter-
mining step would not be the production of MHb from
HbO2.
Phenylhydrazyl radical (PHZR) is the most likely can-
didate to carry out this reduction. One-electron trans-
fers to 02 from heme-Fe" and from PHZ would form
PHZR and Fe"' within the heme cavity. Since PHZR
should be a much better reducing agent than PHZ itself,
and since PHZR should not have to diffuse a significant
distance to find Fe"' to act as an electron acceptor, rapid
reduction of MHb to Hb should ensue.
Consideration of the above paragraphs indicates that
caution should be used in regarding the chemistry oc-
curring in a given HbO2-PHZ or MHb-PHZ system as
being exclusively due to the reactions of one species or
the other. Depending on the initial reaction conditions,
both of these species could be important contributors
to the total chemistry observed during the time period
of interest.
SmaU Molecule Products. Below we will discuss
the various small molecules, both stable and unstable,
that have been observed in the reaction of HbO2 and
MHb with PHZ. In view ofthe discussion above, caution
must be exercised in assuming that these products arise
only via reactive pathways from either HbO2 or MHb,
solely on the basis of the initial form of the hemoglobin
used to initiate the reaction.
Benzene and Nitrogen Formation. Nitrogen was
identified as a final product in the reaction of HbO2 by
Nizet (13) in 1946. Beaven and White (12) confirmed this
and also determined that benzene (PH) was a final prod-
uct in the reaction of oxyhemoglobin with PHZ; PH was
also observed when MHb was reacted with PHZ in the
presence of 02 (12). The amount of benzene produced
in the HbO2-PHZ reaction was found to be less when
the atmosphere above the reacting system was anaer-
obic rather than aerobic (12). Augusto et al. (24) deter-
mined the relationship between the amount of oxygen
consumed, PHZ consumption, and benzene formation
as a function of initial PHZ/heme ratio in the "fast
phase" of reaction in both the HbO2-PHZ and MHb-
PHZ systems. They found that, in either system, one
molecule of unbound oxygen was consumed per PHZ
reacted. At high PHZ/heme ratios (eg. 75) the fraction
of the phenyl groups from PHZ that could be recovered
as benzene was about 5/6, the remainder becoming at-
tached to heme. The same conclusions were reached for
the MHb-PHZ system. In view of these observations,
Augusto et al. (24) were able to write the partial stoi-
chiometric relationship (4)
6PHZ + 602 + 1heme-* 5PH + 1heme (modified) (4)
Goldberg and Stern (30) studied the kinetics of PH
formation in both the MHb-PHZ and HbO2-PHZ sys-
tems. They found that addition of catalase almost com-
pletely inhibited the reaction in the MHb system, in-
dicating a role for scavengable hydrogen peroxide in the
oxidative pathway leading to PH formation. Catalase
did not inhibit the corresponding reaction in the HbO2-
PHZ system. Addition of thiocyanate also completely
inhibited the rate ofPH formation in the MHb-mediated
oxidation of PHZ, but had a much smaller effect on the
corresponding HbO2 reaction. This was taken as an in-
dication that MHb has a peroxidase-type activity for
which PHZ and SCN- compete. This type of MHb-
peroxidase activity evidently does not lie on all path-
ways of benzene formation mediated by HbO2.
Incubation of carbon monoxyhemoglobin (HbCO)
with PHZ under air does not lead to benzene formation
(30). This indicates that bound 02 plays an essential role
in the HbO2-mediated oxidation of PHZ to PH.
In summary, oxidation of PHZ to benzene by MHb
requires that hydrogen peroxide be present; this H202
evidently comes from the medium as it is accessible to
catalase. In the corresponding HbO2-mediated oxida-
tion, H202 that is accessible to catalase is not essental.
However 02, bound to the heme Fe",, is required in
order for oxidation of PHZ to benzene to occur. The
stoichiometry of both the MHb and HbO2 reactions is
such that for each molecule of PHZ reacted, one mol-
ecule of oxygen is consumed from the surrounding so-
lution; at high PHZ/heme ratios five molecules of ben-
zene are generated per phenyl moiety attached to a
heme.
Hydrogen Peroxide Formation. Rostorfer and
Cormier (29), using a chemiluminescence technique to
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assay H202, provided the initial evidence that hydrogen
peroxide (or compounds that behaved like H202 in their
reaction with luminol) were produced in reacting HbO2-
PHZ systems. The production of H202 itself in the re-
action of oxyhemoglobin with PHZ was more defini-
tively demonstrated by Cohen and Hochstein (14). This
conclusion, drawn from studies on HbO2-containing
erythrocytes, was based on an indirect detection tech-
nique that utilized the fact that catalase is irreversibly
inactivated by 3-amino-1,2,4-triazole when H202, pro-
duced by the HbO2-PHZ reaction, is metabolized.
There is not unequivocal evidence that MHb can in-
teract with PHZ and oxygen to form hydrogen peroxide.
The assay methods used by Rostorfer and Cormier (29)
and Cohen and Hochstein (14) indicated that H202 was
formed when MHb (29) and MHb-erythrocytes (14)
were incubated aerobically with PHZ. In both cases,
however, the authors pointed out that HbO2, produced
by reduction of MHb followed by reoxygenation, could
be the actual generator of hydrogen peroxide. Another
potential contributor to formation of H202 in any aer-
ated PHZ system is the aerobic autooxidation of this
compound. The formation of H202 in aerated PHZ sys-
tems in the absence ofMHb was noted by both Rostorfer
and Cormier (29) and Cohen and Hochstein (14). Studies
on the kinetics of oxygen uptake in reacting MHb-PHZ
systems (24), discussed in a subsequent section, support
the argument that an autooxidation reaction is the prime
contributor to H202 formation at the beginning of re-
action, with other pathways strongly contributing at
later times.
Superoxide Anion. Goldberg and Stern were the
first to report (15) that superoxide anion is present in
both reacting HbO2-PHZ and MHb-PHZ systems.
They based these conclusions on obervations of the in-
hibitory effects of superoxide dismutase (SOD) on the
rate of reduction of ferricytochrome C and the rate of
oxidation of epinephrine; similar results were later ob-
tained by Jain and Hochstein (31) with ferricytochrome
C. Misra and Fridovich (17) reached the same conclusion
for the HbO2-PHZ system, finding the SOD inhibited
the rate of reduction of nitroblue tetrazolium; however
MHb was reported not to cause reduction of this com-
pound under the same conditions. The identification of
02, accomplished by the indirect assays described
above, was confirmed by its direct detection in a react-
ing HbO2-PHZ system, using stopped flow electron
paramagnetic resonance (EPR) spectroscopy (32).
An extensive study of the inhibitory effects of various
substances on the rate of production of 02 was carried
out by Goldberg et al. (30). In the case of the MHb-
PHZ system, they concluded that generation of super-
oxide was a consequence ofperoxidase activity by MHb,
acting on PHZ in the presence of H202. An earlier study
by the same workers (15) had shown that catalase
caused almost complete inhibition of superoxide pro-
duction in this system. The mechanism of 02 formation
differs in the HbO2-PHZ system from that in the cor-
responding MHb system. Although addition of thiocy-
anate anion to MHb-PHZ systems effectively inhibited
superoxide production, it has only a partial inhibitory
effect in the HbO2-PHZ system. The SCN- evidently
acts as a substrate for the MHb peroxidase and thus
effectively competes with PHZ for this activity (30). It
can be concluded that a pathway, other than one in-
volving MHb peroxidase action on PHZ, leads to su-
peroxide formation in the oxyhemoglobin-PHZ system.
That this pathway was not one involving simple au-
tooxidative dissociation ofHbO2 was shown by Goldberg
et al. (30). The fact that partial inhibition is observed
could indicate that MHb, generated from reaction with
HbO2 by another pathway, does contribute, via the per-
oxidase reaction, to the oxidation of PHZ. In line with
this idea is the observation that catalase also causes
partial inhibition of superoxide formation in the HbO2-
PHZ system (15,30); almost total inhibition is observed
in the MHb-PHZ system (15).
The noninvolvement of superoxide as a reactant in
the pathway leading to PH formation, in either the
HbO2-PHZ or MHb-PHZ system, was demonstrated
by Goldberg et al. (30) through the observation that
SOD has no effect on the rate of production of this
compound. The important role of bound oxygen in ini-
tiating those reactions leading to superoxide formation
is indicated by the inability of carbon monoxyhemoglo-
bin to produce 02 in aerated PHZ solutions (30).
To summarize, in the MHb-PHZ system both 02
formation and oxidation of PHZ to benzene are depen-
dent on a MHb-peroxidase activity with hydrogen per-
oxide, accessible to catalase, being involved as an es-
sential component of the reaction. In the
oxyhemoglobin-PHZ system, two pathways to 02 and
PH formation, one of them independentt of this MHb-
peroxidase activity, probably exist. In both systems,
PHZ oxidation to benzene does not involve superoxide
as reactant.
What is the source of superoxide in HbO2-PHZ and
MHb-PHZ systems? Goldberg et al. (30) suggest that,
in each case, the operative reaction pathways lead to
phenydiazene (PDA) as a product. This substance is
known to rapidly react with oxygen to yield PH and
phenyl radical (18). When Goldberg et al. (30) generated
PDA in aerated solution, they found that 02 was rap-
idly formed, supporting its candidacy as as a precursor
of superoxide anion in hemoglobin-PHZ reactions. An-
other possible precursor of 02, suggested by Misra
and Fridovich (17), is the phenylhydrazyl radical. This
species should be a very good reducing agent and should
readily react with 02 to yield°2 -
The Phenyl Radical and Other Drug-Derived Rad-
icals. Goldberg and Stern first suggested (33) that the
phenyl radical (PR) could play a role in the chemistry
of hemoglobin-PHZ systems. Its actual presence in re-
acting HbO2-PHZ and erythrocyte-PHZ systems, was
demonstrated by Hill and Thornalley (16). They inter-
cepted the PR in these systems, using 5,5-dimethyl-1-
pyrroline-l-oxide (DMPO) as a spin trap and detected
its characteristic EPR spectrum. A paper from the
group of Ortiz de Montellano (34), appearing a short
time later, indicated that they had also trapped this
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radical using similar techniques. Later studies by Hill
and Thornalley (35) showed that other spin traps were
equally or more effective in trapping PR.
What is known about the reactive pathways leading
to the PR observed in spin-trapping experiments? The
most likely immediate precursor of PR is the pheny-
ldiazenyl radical (PDAR), formed via loss of an electron
from PDA to 02 (30,33). As will be discussed below,
PDA is one of the probable products of the early steps
of the reactions of either HbO2 or MHb with PHZ. It
is also likely to be an intermediate in any chain mech-
anisms leading to PHZ oxidation. Thus there should be
ample supplies of PDA around to act as a precursor for
PDAR and PR formation.
Some information has been obtained, relevant to the
mechanism of PR formation, via kinetic studies. Au-
gusto et al. (24) and Hill and Thornalley (36) found that
DMPO caused a significant lowering of the rate of 02
consumption in HbO2-PHZ (24,36) and MHb-PHZ (24)
systems during the "fast phase" of reaction. Since Au-
gusto et al. (24) showed that 1 PHZ was consumed per
02 taken up from solution, this implies that interception
of PR is reducing consumption of PHZ. The most likely
explanation of this is that PR is a chain carrier in a chain
reaction consuming 02 and PHZ.
Although the phenylhydrazyl radical (PHZR) and
PDAR are almost certainly involved in the chemical
processes occuring in hemoglobin-PHZ systems, and
are discussed in this context throughout this review,
there have not been full literature reports of their direct
detection by spin-trapping or other techniques. How-
ever, in 1978, French et al. (37) cited unpublished work
by Winterbourn and Gilbert that indicated that PHZR
had been detected in the HbO2-PHZ system, rather
than PR, using EPR spectroscopy and spin trapping.
Details have evidently not been published.
Heme-Modified Products. The brown colora-
tion imparted to blood by PHZ (8) and the brown-green
color given to erythrocyte suspensions by PHZ and N-
acetylphenylhydrazine (APHZ) (9) has been known
since the last century. Beaven and White (12) noted
that incubation of HbO2 with various phenylhydrazines
led to alteration of the protein and its precipitation as
"green hemoglobin." Because of the likely involvement
of this substance in Heinz body formation, a significant
amount of research effort has been devoted to under-
tanding the nature of green hemoglobin and the pro-
cesses leading to its formation.
The first step towards determination of the chrom-
ophore responsible for the green color of the modified
hemoglobin was taken by Beaven and White (12). They
made green hemoglobin by reacting HbO2 with APHZ
and extracted the green pigment from the precipitate
with acetone. Using this extract, they demonstrated its
protoheme nature, studied its electronic absorption
spectrum, and determined some of its chemical prop-
erties.
The chemical nature of the modified heme, free from
globin, was established almost simultaneously by pa-
pers from the laboratories of Ortiz de Montellano (19)
and Itano (38). Both groups isolated protoporphyrin IX-
containing green pigment as the dimethyl ester by treat-
ing the product from reaction of HbO2 with PHZ with
acidic methanol under air and used spectroscopic and
mass spectrometric techniques to make structural as-
signments. The esterified pigment was shown to consist
of compounds of structural type given by I. Using the
Zn 2 complex, Ortiz de Montellano and Kunze (19) were
able to demonstrate, via chromatographic and NMR
techniques,the presence of four isomeric forms, while
Saito and Itano (38) presented chromatographic evi-
dence for at least three isomers. The latter workers also
isolated and structurally characterized the same pig-
ment from the oxymyoglobin (MbO2)-PHZ system as




Using the same procedures, Saito and Itano (38) also
isolated and characterized-although in significantly
lower yields than I blue pigments from reacted HbO2-
PHZ, MbO2-PHZ, and MbO2-p-tolylhydrazine sys-
tems. They established the structure of these pigments
to be of the type shown in II. In the case of the HbO2-
PHZ system, an additional minor blue pigment was also
noted.
The characterized blue pigment, which is a modified
biliverdin, is evidently formed via a coupled process
involving oxidative opening of the porphyrin ring and
phenylation at carbon.
The N-phenylporphyrin formed in the HbO2-PHZ re-
action was also produced in the aerobic reaction of MHb
with PHZ (19,24). Oxymyoglobin and metmyoglobin
likewise reacted with PHZ to form N-phenylporphyrin
that could be extracted as I; however these modified
myoglobins do not precipitate as is observed in the case
of the corresponding hemoglobins (39).
While esterified N-phenylprotoporphyrins are the
products extracted from PHZ-treated HbO2 or MHb by
acidified methanol, it is becoming evident that these
species are derived from rearrangement of a globin-
stabilized u-bonded phenyl-iron complex (24, 39-41).
The initial suggestion of the existence of such a complex
in hemoglobin reacted with PHZ was contained in the
work of Augusto et al. (24). Their conclusion was based,
in part, on the observation that acidified methanol ex-
traction of modified porphyrin yielded dramatically dif-
ferent amounts ofgreen pigment, depending on whether
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the extraction procedure was carried out under N2 or
air. Much less I was obtained under N2 than under air;
significant amounts of unmodified protoporphyrin IX
dimethyl ester were also obtained under N2, while un-
der air almost no unmodified porphyrin was found.
These observations are consistent with the existence of
a globin-stabilized complex that can either revert to
protoporphyrin IX or undergo rearrangement to give
the N-phenylprotoporphyrin, depending on work-up
conditions. Various experimental observations led Au-
gusto el al. (24) to favor the a-bonded phenyliron com-
plex (III) as this intermediate, rather than a species
involving coordination of PHZ or its oxidation product
(PDA) to iron. For example, one observation that dis-
counted the possibility of a PDA complex with iron was
that cyanide, dithionite, and ferricyanide were without
effect on the complex. However, these same reagents
react readily with the nitrosobenzene-myoglobin com-




Later studies by the Ortiz de Montellano group
(39,41) have supported their suggestion that a globin-
stabilized u-bonded phenyliron complex is the precursor
to the N-phenylprotoheme extracted by acidified meth-
anol. Kunze and Ortiz de Montellano (39) found the cr-
II
complex could be extracted from arylhydrazine-modi-
fied protein by treating it with argon- saturated 2-bu-
tanone containing butylated hydroxytoluene. They com-
pared the ultraviolet spectrum of the extracted complex
from PHZ-treated hemoglobin and an authentic com-
plex of the phenyl-heme complex, prepared by a syn-
thetic method, and found them to be identical. In ad-
dition, they obtained the 240 MHz NMR spectrum of
both PHZ-and p-tolyl hydrazine-treated MbO2 and
showed that the observed peaks were consistent with
those expected for a a-bonded aryliron complex. Evi-
dence from absorption spectroscopic studies also sug-
gests the formation of III in the MHb-PHZ system (41).
Very recently X-ray diffraction studies have confirmed
that the phenyl group is bound to iron in PHZ-modified
metmyoglobin and, at the same time, shed light on the
mechanism by which 02 reaches the interior of oxygen-
binding heme proteins (42).
The conversion of u-bonded phenyliron porphyrins to
N- phenylporphyrins has been studied in a number of
model systems. Ortiz de Montellano et al. (43) synthe-
sized the u-bonded phenyliron complex of iron tetra-
phenylporphyrin (FeTTP) and showed that the spectral
data for this complex were consistent with iron being
in the ferric form. Though the solid complex was stable
in air, it decomposed rapidly in solution, in the absence
of butylated hydroxytoluene (HBT), to give benzene
and FeTPPCl as products (43). Biphenyl and phenol
were absent as products, suggesting that benzene was
produced from reaction of the phenyl carbanion with
water. Treatment of the phenyl FeTTP (PhFe",'TTP)
with acidified methanol, in the presence of BHT, led to
formation of the N-phenyl FeTTP in 68% yield over the
course of a couple of hours. When oxygen was excluded,
the yield of N-phenyl FeTTP decreased dramatically.
These workers also found that the same behaviour could
be observed with the chemically synthesized u-bonded
phenyliron complex of protoporphyrin IX.
Mansuy and coworkers (40) also studied the phenyl
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migration reactions of PhFe"'TTP and found that re-
versible transfer could be achieved. Upon treatment of
PhFe"'TTP with the oxidizing agent, FeC63, the phenyl
group is transferred from iron to nitrogen with accom-
panying reduction of the ferric iron form to the ferrous
state. (This observation suggests that 02 also acts as
an electron acceptor in the aerobic migration of phenyl
from iron to nitrogen, described in the preceding par-
agraph. If so, then 02 should be an expected product
in this reaction.) The reverse transfer, of a phenyl group
from a pyrrole nitrogen to iron, occured on treatment
of the N- phenyl FeTTPCl with the reducing agent di-
thionite.
Are there detectable complexes, involving iron and
PHZ (or PHZ oxidation products), that act as precur-
sors to formation of the a-bonded phenyliron complex
in the reaction of HbO2 with PHZ? Such intermediates
have been looked for, but not yet detected (22). How-
ever, they have been found in HbO2-and MbO2-methyl-
hydrazine (MHZ) systems (22). The reactions of HbO2
or MbO2 with excess MHZ, in the presence of oxygen
at a 10:1 molar rate to protein, gave almost quantitative
yield of a complex with a characteristic visible absorp-
tion spectrum. Addition of the reducing agent dithionite
to the Mb complex had no effect on the spectrum, but
addition of CO resulted in formation of MbCO. Such
observations led to the identification of such substances
as Hb-methyldiazene (MDA) and Mb-MDA complexes,
with the MDA probably bound to the Fe", via the ni-
trogen a to the methyl (22). A similar complex was
observed when MDA was added under anaerobic con-
ditions to Mb, supporting the above conclusions about
the nature of the substance. That the Fe",-diazene com-
plex can act as a precursor for a-bonded alkyliron com-
plexes is indicated, for the Mb-MDA complex, by the
observation that its treatment with either ferricyanide
or oxygen leads to formation of a compound with a spec-
trum characteristic ofthe cr-bonded methyliron complex
III. The same protocols, applied to the reaction of HbO2
and MbO2 with PHZ, or of Hb and Mb with PDA, did
not lead to detection of similar observable heme-diazene
intermediates (22). In this regard, it is interesting to
note that Huang and Kosower (44) found that anaerobic
addition of PDA itself, at a PDA/heme ratio of about
1.1, did not cause a change in the absorption spectrum
of the protein. The added PDA could, however, be de-
tected in the presence of Hb via its ultraviolet absorp-
tion spectrum. In anaerobic solution, in the absence of
Hb, PDA undergoes a slow, OH--catalyzed decompo-
sition process; however, when 02 is admitted, the PDA
undergoes extremely rapid destruction (44). In the pres-
ence of Hb, however, this 02-mediated destruction of
PDA occurred at a much reduced rate, as monitored by
disappearance of its UV spectrum (44). Huang and Ko-
sower (44) suggested that the PDA had become com-
plexed to Hb at a site located within the globin portion
of the heme protein, rather than at the heme itself
Admission of 02 did not cause a change in the Hb ab-
sorption spectrum, other than that expected due to
mere reoxygenation to HbO2. Although the HbO2 spec-
trum did appear, it was reduced about 10-20% in in-
tensity from that expected. This type of behavior, in
fact, is that observed in the early stages of the reaction
of HbO2 with PHZ to form III [see, for example, the
spectra of Itano and Matteson (25)].
Somewhat analogous behavior ofMDA and PDA, to-
wards formation of complexes with Fe"', has been ob-
served in model heme systems. Reaction of Fe"'TTP
with excess MDA, under anaerobic conditions, led to
an isolatable complex whose structure was assigned to
Fe",TPP(MDA)2 (45). Oxidation with 02 or FeCl3 gave
the u-bonded Fe"'TPP(CH3) complex. Reaction of
Fe",TPP with PDA did not yield the corresponding iso-
latable product, Fe"'TPP(PDA)2 but instead the cor-
responding u-bonded phenyl Fe "(TPP) complex was
isolated. However, under strictly anaerobic conditions,
a visible absorption spectrum attributed to a Fe-
"TPP(PDA)2 complex was observed. Even traces of 02
resulted in the fast transformation of this substance to
the u-phenyl Fe"' complex (45).
Summarizing, the experimental evidence points to at
least one, and possibly two, intermediates on the path-
way to formation of N-phenylated heme, the chrom-
ophore of the "green hemoglobin" of Beaven and White
(12). The presursor of the N-phenylheme moiety is a
globin-stabilized u-bonded phenyliron complex (III)
which rearranges in the presence of electron acceptors
to give N-phenylated porphyrin. In HbO2-MHZ sys-
tems, a heme Fe"'-MDA complex has been detected
but is readily transformed into III. A similar heme
Fe",-PDA complex has not been detected; however,
there is evidence that a globin-PDA complex exists and
this could act as a precursor to III.
In addition to the knowledge concerning the nature
of heme modification reactions, described above, there
is also relevant published information concerning the
kinetics of heme modification. Itano and Matteson (25)
have spectroscopically studied the rate of disappearance
ofHbO2, induced by PHZ, under conditions where HbO2
was present in excess. In the absence of catalase and
SOD the system did not display second order kinetic
behavior over the entire course of reaction. When cat-
alase and SOD were both present in sufficiently large
concentrations, however, strict second-order kinetic be-
havior was found. The corresponding rate law under
these conditions was found to be d(HbO2)/dt = - 64 L/
mole-sec [HbO2][PHZ]. These workers interpreted
their data as indicating the HbO2 was disappearing via
a bimolecular reaction to form a product with a char-
acteristic visible absorption spectrum. Although they
did not identify the product, they proposed that it re-
sulted from a two electron transfer from PHZ to HbO2.
Comparison of the spectrum presented by Itano and
Matteson (25), however, with the spectral data shown
and described, respectively, by Mansuy et al. (22) for
the myoglobin-u-phenyliron complex and the hemoglo-
bin-u- phenyliron complex very strongly suggests that
the absorbing product formed under their reaction con-
ditions was hemoglobin containing the u-phenyliron-
heme complex III. If one assumes that HbO2, under
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these conditions, reacts exclusively in the presence of
PHZ to form III then the rate law for formation of III
will be given by d(III)/dt = 256 L/mole-sec [HbO2] [PHZ]
(each hemoglobin contains four heme units). If other
heme products with relatively small extinction coeffi-
cients over the spectral range between 500 and 600 nm
(compared to HbO2 and hemoglobin containing III) are
also formed, then 256 L/mole-sec would be an upper
limit for the rate constant for formation of III.
In the absence of catalase and SOD, the rate constant
for disappearance of HbO2 (evaluated from initial rate
data) was found to be about 110 L/mole-sec (25). Ad-
dition of either catalase or SOD individually to such
systems lowered the initial rate of disappearance, but
did not cause strict second-order kinetic behavior to be
followed. Only addition of both SOD and catalase to
sufficiently high concentrations accomplished this. Itano
and Matteson (25) interpreted this to indicate that re-
actions of 02 and H202 with HbO2, to form MHb, were
important factors in causing the disappearance of HbO2
in the absence of catalase and SOD. Addition of SOD
removed the contribution of superoxide to this process,
but increased the level of H202 present in the reacting
system. Catalase addition resulted in the removal of
hydrogen peroxide, but did not stop the reaction of
HbO2 with 02. Addition of both of these substances
evidently is required to minimise removal of HbO2 via
pathways forming MHb (25).
An independent estimate of the rate of formation of
III in the HbO2-PHZ system can be made by using the
data of Augusto et al. (24). They found that the rate of
02 consumption was given by d(02)/dt = - 55 L/mole-
sec [heme][PHZ] when PHZ was present in excess and
when catalase and SOD were absent. Since, under these
conditions, 6 oxygen molecules are consumed per heme
modified (presumably to III) and since each HbO2 con-
tains four heme groups, the above rate law can be re-
written as d(III)/dt = 37 L/mole-sec [HbO2][PHZ]. This
value for the second-order rate constant is considerably
smaller than the maximal value obtained from the work
of Itano and Matteson (25); however, it is probably not
fruitful to worry about this until complete heme product
characterization in the HbO2-PHZ system is accom-
plished, using the conditions under which each of these
studies was made.
As was pointed out above, calculations for the MHb-
PHZ system, again using data from the paper of Au-
gusto et al. (24), yield an estimate of 16.5 L/mole-sec
for the rate constant for formation of III in this system.
Reactions of Hemoglobin with
Phenylhydrazine: Mechanism
Introduction
In the last section we discussed the products formed
in the reactions ofHbO2 and MHb with PHZ, along with
evidence relevant to understanding the pathways by
which these individual products were formed. In this
section we present a mechanistic scheme that attempts
to integrate this, and other experimental information,
into a manageable overall picture ofwhat happens chem-
ically when HbO2 or MHb reacts with PHZ to form
hemoglobin containing III under aerobic conditions. (A
schematic representation of this mechanism is given in
Figure 1.) As additional experimental evidence becomes
available, the scheme presented here will undoubtedly
require modification; however, it may be useful as a
starting point for the design of experiments to fill gaps
in our understanding of the mechanism of the reaction
of hemoglobin with PHZ.
Before proceeding to our mechanistic discussion,
some remarks will be made concerning the time scale
over which aerobic reactions of hemoglobin with PHZ
occur and about how PHZ, and its oxidation products,
gain access to heme in their reactive encounters with
hemoglobin.
Although the exact time required for destruction of
HbO2 depends on the initial concentration of HbO2 and
PHZ, it is on the order of minutes. With 5uM HbO2 and
1.0mM PHZ, for example, the oxyhemoglobin present
was almost completely converted to modified hemoglo-
bin, probably predominately III, in about 2 min (24). A
similar fast reaction leading to modification of heme,
was observed in the MHb-PHZ system (24). In this
system, however, an induction period on the order of a
minute was required before the reaction, to form mod-
ified heme and oxidize PHZ, entered the fast reaction
phase. Evidently hydrogen peroxide production, via an
oxidative process not mediated by MHb, occurs during
this induction period, and this H202 is essential for the
MHb-mediated oxidation to take place (24). This idea is
supported by the fact that inclusion ofH202 in the MHb-
PHZ system eliminates the induction period. After the
fast phase of 02, PHZ and hemoglobin consumption ox-
ygen continues to be consumed in the presence of excess
PHZ, although at a much reduced rate (24). This re-
action, which is about twice as fast as consumption of
02 in the absence of hemoglobin, evidently does not
involve either HbO2 or MHb (which are consumed dur-
ing the preceding fast phase of reaction).
Because of the multiphase kinetic behavior in aerobic
hemoglobin-PHZ systems, care must be taken in de-
ciding whether data from the literature support a pro-
posed mechanism for the processes occuring in these
systems. In the following discussion, we will be inter-
ested in the mechanisms of the reactions occurring in
the fast phase of reaction in hemoglobin-PHZ systems
and thus we will emphasize data that have been gath-
ered over reaction times that are reasonably close to
those spanned by the fast reaction phase.
What is the spatial relationship between PHZ and the
heme and globin portions of hemoglobin during redox
processes involving PHZ and hemoglobin? Detailed in-
formation relative to this problem is not available; how-
ever recent X-ray diffraction studies by Ringe et al. (42)
have shown that the phenyl moiety ofthe a- phenyliron-
heme complex (III), formed by the reaction ofPHZ with
metmyoglobin, is located in a channel that extends from
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FIGURE 1. Proposed mechanistic scheme indicating the pathways of reaction of hemoglobin with phenylhydrazine. The bracketed term [H20]
represents products of unknown identity, as discussed in the text.
the heme cavity to the protein surface. This channel
results from significant displacement of several amino
acid residues from their positions in unmodified met-
myoglobin. Ringe et al. (42) have suggested that li-
gands, such as oxygen or carbon dioxide, binding at a
site involving amino acids in, or close to, the site of
channel formation, could trigger conformational
changes that open the channel and allow access to the
heme cavity. In view of the fact that the phenyl group
occupies the channel in modified myoglobin, it seems
reasonable to speculate that PHZ and its oxidation prod-
ucts (PHZR, PDA, and PDAR) occupy a channel of
similar nature during their reactive interactions with
heme groups in hemoglobin and that binding of these
molecules at or near the site of channel formation in-
creases the likelihood of hemoglobin being in a confor-
mational state where the channel is open. Our proposed
mechanistic scheme for formation ofa-phenyliron-heme
in hemoglobin-PHZ systems (Figure 1) assumes that
this is the case.
With regard to the possibility that PHZ and its oxi-
dation products can act as effective triggers for channel
formation in hemoglobin, it is interesting to note that
diazene itself is isoelectronic with oxygen while hydra-
zine is isoelectronic with hydrogen peroxide. If indeed
the opening of the channel, discovered by Ringe et al.
(42), is triggered by binding of 02, then it is not sur-
prising that PDA, containing a group with marked elec-
tronic similarities to oxygen, could also cause the chan-
nel to be opened. One can further speculate that H202
enters the heme cavity ofhemoglobin via the same chan-
nel and has the same type of trigger mechanism as ox-
ygen; then one would also expect PHZ to display the
ability to trigger conformational changes that would
bring the hydrazino group into the heme cavity. This
could account, in part, for the high effectiveness ofphen-
ylhydrazine and related hydrazines as agents in car-
rying out reductive reactions in the heme cavity, as
compared to other reducing agents (26).
Mechanisms of Formation of o-
Phenyliron-heme Complexes (III)
In this section we focus on the means by which the
interaction of PHZ with hemoglobin in aerated solution
produces modified hemoglobin containing the heme com-
plex III. As discussed above, there is strong evidence
that production of benzene and 02 in HbO2-mediated
oxidation on PHZ occurs via at least two distinct path-
ways. One of these putatively involves the action of a
MHb peroxidase on PHZ, while the other(s) do not.
There is not yet direct evidence available that III is
similarly formed by more than one pathway in HbO2-
PHZ systems. However, as pointed out above, the rate
of formation of III in the fast phase of reaction in the
HbO2-PHZ system is about 2.3 times as fast as the
corresponding rate in the MHb-PHZ system. This sug-
gests that a second pathway exists for formation of III,
not involving passage over the MHb-mediated route to
this substance.
In this section we first discuss our proposed route to
formation of III in aerobic MHb-PHZ systems. The
same pathway also accounts for the formation of III as
observed in anaerobic MHb-PHZ-H202 systems (41).
This pathway, steps A, B, C, E, and M in Figure 1,
leads from MHb to III without passage through Hb or
HbO2. [A second, much slower, pathway (reaction N)
to the same product, also not involving HbO2, will be
discussed later.]
Several lines of evidence point to the involvement of
H202 as an essential reactant in the fast reaction ofMHb
with PHZ to form III and PHZ oxidation products. The
strongest indication is provided by the work of Ortiz de
Montellano and Kerr (41), who incubated excess PHZ
with MHb under N2 for 30 min. During this period,
[MHb
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there was no spectroscopic indication of formation of III
within the system. When H202 was added to this an-
aerobic system, after the 30 minute incubation period,
then the spectrum was immediately converted to that
characteristic of ferrylhemoglobin (HbFeIVO) (46,47)
and then, over a period of several minutes, to that of
III. (Oxygen was not required for this transformation;
presumably, under the anaerobic conditions used, step
E is replaced by OH--mediated decomposition of PDA).
Formation of modified heme during the fast phase of
the reaction of MHb with PHZ is coupled to consump-
tion of 02 and PHZ and production of benzene by the
stoichiometric relationship (24)
6 PHZ + 602 + 1 heme -. 5PH + 1 heme (modified)
The addition of catalase to MHb-PHZ systems both
lengthens the induction period preceding the fast re-
action phase, as measured by oxygen consumption, and
also lowers the rate of 02 consumption during the fast
phase itself (24). The former effect is accounted for by
assuming that the H202 required to enter reaction A in
a MHb-PHZ system, initially free of H202, must be
generated by non-MHb-mediated autoxidation of PHZ;
the presence of catalase increases the time required to
produce an H202 concentration high enough to form the
levels of MHb-H202 needed to initiate the fast phase of
reaction. Catalase, by lowering the concentration of
H202 during the fast phase of reaction, would also de-
crease the steady state concentration of MHb'H202 and
HbFeIvO present during this phase and thus lower the
rates of consumption of PHZ and 02 and, by stoichi-
ometry, the rate of formation of III. [Catalase also com-
pletely inhibits the formation ofPH and 02 during the
fast phase of reaction (15,30) as will be discussed in a
subsequent section.]
Ferrylhemoglobin (HbFeIvO) is putatively the key
component of the MHb-peroxidase activity discussed by
Goldberg et al. (30). The mechanism in Figure 1 differs
somewhat from their postulated mechanism which sug-
gests that one molecule ofPHZ reduces two ferrylhem-
oglobins to MHb and PDA. Our variation indicates that
one molecule of PHZ transfers two electrons to Hb
FeIvO to yield [Hb-PDA]. This latter reaction leaves
the heme group in the proper oxidation state for reac-
tion M of Figure 1 to occur.
Statements as to the nature of Hb-PDA are neces-
sarily highly speculative. However several experimen-
tal observations provide some guidance for speculation.
The existence of a Hb-PDA complex, with the diazenyl
moiety protected from oxidation by oxygen, is implied
by the work of Huang and Kosower (44). Exposure of
this complex to 02 results in decomposition within a half
life of several hundred seconds, while PDA in solution
is completely destroyed with 10-15 sec (44). Although
PDA itself does not fonn a spectroscopically detectable
complex with Hb- or Mb- heme Fe"', the related meth-
yldiazene (MDA) does (22). This complex is similarly
protected from 02 in solution; indeed 15 minutes of ex-








FIGURE 2. Proposed mechanistic scheme depicting the reactions in-
volved in phenyl radical-mediated oxidation of phenylhydrazine.
for its conversion to a cr- methyliron-heme complex.
The fact that Huang and Kowsower (44) noted that
about 10-20% of the Hb-PDA complex was not re-
covered as HbO2 after admission of 02 suggests that an
analogous reaction was occurring in this system. If one
assumes that MDA is associated with Hb via embed-
ment in a channel passing from the surface of the protein
to the heme, with the diazenyl group complexed with
the heme, then it is reasonable to assume that PDA is
associated with the same channel. However, its position
within the channel must be different, so as to account
for the fact the diazenyl group does not interact strongly
with heme. (Perhaps stronger hydrophobic interactions
of the phenyl moiety with amino acids in the channel,
as compared to the methyl group of MDA, or the ad-
ditional bulk of the phenyl group tend to displace PDA
to a position of diminished entry into the channel, as
compared to MDA.) Presumably, oxygen gains access
to diazene in Hb-diazene complexes because they
undergo conformational fluctuations that place the
bound diazene in contact with the surrounding medium.
Oxidation of the diazene to PDAR with accompanying
formation of 02- (18, 30, 33), would follow reaction E.
Another possibility is that 02 penetrates slowly to the
heme cavity via an alternative channel and oxidation of
PDA occurs within the cavity.
The PDAR formed in reaction E, retaining structural
elements of the diazene moiety, is assumed in Figure 1
to remain bound to hemoglobin. However, PDAR is
known to rapidly lose nitrogen to form phenyl radical
(18,33). The proposed scheme in Figure 1 indicates that
the resultant phenyl radical can react (reaction M) with
heme Fe", via a process that involves electron transfer
from iron to the phenp4 radical to form a complex in
which iron is in the Fe' state; this latter oxidation state
is the one that has been observed in studies of the same
types of reaction in model porphyrin systems (40,43,45).
Alternatively, the phenyl radical can escape into the
surrounding medium (reaction F) where it can react
with PHZ or other ambient hydrogen donors to produce
benzene (reaction S and U in Fig. 2).
The conversion of MHb-H202 to ferrylhemoglobin
(step B of Fig. 1) is accompanied by the release of a
stoichiometric equivalent of one molecule of H20'. The
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actual chemical nature of the product(s) released is un-
known (46). The same statement holds for the stoichi-
ometric equivalent of water or H20'released in reac-
tions C, K, and L.
In addition to the H202-mediated pathwpy leading
from MHb to formation of the Hb-PDA complex, de-
scribed above, an additional pathway to the same end
should be considered, namely that indicated by N in
Figure 1. This is the pathway leading to reduction of
MHb by PHZ under anaerobic conditions. Under these
conditions, one PHZ is able to reduce two heme units,
one via electron transfer from PHZ itself to Fe"' and
the second presumably via electron transfer from PHZR
to Fe,". This second step would be expected to produce
a Hb-PDA complex, as indicated in reaction N. Two
factors discount the possibility that reaction N is a sig-
nificant pathway to III under aerobic conditions.
Firstly, assuming the first step is rate-determining (26),
the transfer of an electron from PHZ to Fe"' under
anaerobic conditions is about 50 times slower than the
reaction of MHb to yield modified hemoglobin under
aerobic conditions. Secondly, the final part of the se-
quence (reaction of PHZR with Fe"' to form Mb-PDA)
requires the transfer of PHZR from a channel on one
heme unit to a channel on another, probably via emer-
gence into the surrounding medium. Under aerobic con-
ditions, reaction of PHZR (and its oxidation product
PDA) with ambient oxygen would probably destroy
these species before they relocated at another channel
site.
As discussed above, it is likely that there are two
pathways leading to formation of III in HbO2-PHZ sys-
tems. Our proposed reaction scheme in Figure 1 indi-
cates that one of these proceeds through a pathway
involving reaction between ferrylhemoglobin and PHZ;
this same reaction is postulated to be a key step in
formation of III in MHb-PHZ systems. We visualize
HbO2 interacting with PHZ, in the common first step
H of these two reactive pathways, to give a
MHb-H202-PHZR complex. Formation of this complex
involves transfer of one electron each from heme Fe"'
and PHZ to oxygen. The MHb-H202 PHZR complex
constitutes a branch point in the reaction scheme of
Figure 1. Loss ofPHZR, before hydrogen peroxide con-
verts MHb to HbFeIVO, sends the reaction in the di-
rection of step J; formation of III would then proceed
as described above. The alternative step K (conversion
of MHb to HbFeIvO before PHZR leaves its putative
binding site within a channel leading to the heme pocket)
would lead to reaction L, which results in conversion of
the resultant ferrylhemoglobin.PHZR complex to
Hb-PDAR. This latter complex is thus the proposed
immediate precursor of III in both reaction pathways.
We have not discussed, in this section, the formation
of modified hemoglobins whose heme group can be ex-
tracted in the form of II (38). As little is known about
possible intermediates on the pathway to this type of
modified hemoglobin, there seems little to be gained by
postulating possible mechanisms for its formation.
Formation of MHb in the Reaction of
HbO2 with PHZ and of Hb in the Reaction
of MHb with PHZ
As discussed above, reaction of PHZ with HbO2,
within the time frame encompassed by the fast phase
of reaction, leads to formation of MHb as a product
(25,28). This probably can be attributed, at least in part,
to oxidation of HbO2 by H202 and 02, produced during
the course of reaction (25). However, some MHb is pro-
duced during the fast phase of reaction when PHZ is
present in limiting amounts, even in the presence of
high concentrations of SOD and catalase (25). In our
scheme, production of MHb occurs as a result of dis-
sociation of MHb-H202 (reaction A'). The presence of
high concentrations of catalase, and of limited amounts
of PHZ, would result in some MHb being left over at
the end of the fast phase of reaction.
The results of Castro et al. (26), in which they found
that oxyhemoglobin, maintained under an argon at-
mosphere in excess of PHZ, was reduced to Hb via a
pathway involving MHb production, can also be under-
stood from the scheme presented in Figure 1. The re-
action direction indicated by step J leads to Hb PDA as
an intermediate; however, with low oxygen concentra-
tions in solution reaction D, yielding Hb as a product,
could become the dominant pathway for decomposition
of this complex. The MHb, trapped by cyanide ion in
these experiments would be that produced by the highly
competitive reaction of 1.6 mM CN- with MHb from
reaction A', as compared to the alternative reaction of
MHb with the small amounts of H202 released by this
dissociative reaction. It is not yet known whether III
is produced as a result of reaction of HbO2 with PHZ
under the conditions employed by Castro et al. nor
whether addition of CN- under these conditions par-
tially or totally blocks formation of other products as-
sociated with oxidation of PHZ by HbO2.
How competitive in HbO2-PHZ systems are pro-
cesses producing Hb (reactions D and F) with reaction
M, which produces III? Some idea can be obtained using
the data of Castro et al. (26). These workers, in their
study of the kinetics of disappearance of HbO2, deter-
mined a rate law of d(HbO2)/dt = -45 L/mole-sec
[HbO2][PHZ] to describe this process. Under their con-
ditions of low oxygen concentration, deoxyhemoglobin
was the dominant product. Interpreting the above rate
law in terms of Figure 1 indicates that 45 L/mole-sec is
a maximal apparent rate constant describing the con-
tribution of both reaction D and the reaction sequences
(E, F) and (L, F) to formation of Hb under these low
oxygen conditions. Increase of 02 concentration would
increase the rate of reaction E and augment the rate of
formation of Hb. Thus the apparent rate constant would
become greater. Since the estimated value of the rate
constant, describing formation of III in aerated HbO2-
PHZ systems, is 37 L/mole-sec and since the maximal
apparent rate constant that would be measured in aero-
bic solution, describing the production of Hb, would be
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larger than 45 L/mole-sec it can be concluded that non-
destructive cycling of hemoglobin is likely to be com-
petitive with pathways leading to modified hemoglobin
in such systems. Even if the rate constant for formation
of Hb under the conditions of Castro et al. (26) is con-
siderably smaller than the maximal value of 45 L/mole-
sec, this qualitative conclusion still holds. The same con-
clusions can be reached for the aerobic MHb-PHZ sys-
tem where some of the same reactions (D, E, F and M)
are involved in partitioning of Hb-PDA and Hb-PDAR
between III and Hb.
Mechanisms of Formation of Benzene,
Superoxide Anion and Hydrogen Peroxide
The small molecule products, resulting from oxidation
of PHZ by HbO2 or MHb, cannot necessarily by de-
scribed as being formed via a single pathway. Indeed,
it is more likely that there are multiple pathways of
formation for each of these products. In the following
we will focus on these possible multiple pathways for
formation of benzene, superoxide anion and hydrogen
peroxide.
According to our mechanistic scheme, there are a
variety of ways that PH could be generated in the fast
phase of reaction in HbO2-PHZ and MHb-PHZ sys-
tems. Production of PR in reaction F (Fig. 1), followed
by abstraction of hydrogen from ambient donors (re-
actions S and U), leads directly to benzene formation.
However, the fact that the spin trap DMPO, which traps
phenyl radicals (16,34), quenches the rate of oxygen
consumption (24,36) in HbO2-PHZ and MHb-PHZ sys-
tem (and hence, from stoichiometric considerations, also
quenches the rate of PHZ consumption and benzene
formation) suggests that PR is involved as a chain car-
rier in reactions leading to further consumption ofPHZ
and production ofbenzene. In Figure 2 we depict a cyclic
process for destruction of PHZ involving PR as a chain
carrier. Reaction steps P, Q, R and S are the key steps
in an oxidation cycle using PHZ as an input substrate.
Phenyl radicals react with PHZ to form PHZR and pro-
duce benzene in step S. The PHZR interacts with 02
in step P to form superoxide anion and PDA. This latter
substance, in turn, reacts with oxygen in R to form 02
and PDAR, which rapidly decomposes to generate ni-
trogen and the phenyl radical, which can initiate another
cycle. The reaction cycle can be terminated by reaction
of PR with ambient hydrogen donors other than PHZ
to yield benzene (step U). If superoxide disproportion-
ation (step T) is included, then the stoichiometry of each
revolution of the cycle works out to be
further oxidation. In both the MHb-PHZ and HbO2-
PHZ reactions, the PDA produced by reaction D can
enter into the cycle via reaction Q; in the HbO2-PHZ
system, PHZR, released in step J, can enter into the
cycle by way of reaction P. As mentioned above phenyl
radical, produced in reaction F in both systems, enters
the cycle via reaction S.
In summary, much of the benzene produced in re-
acting hemoglobin systems may come about as a result
of PHZ oxidation products, produced in reactions of
PHZ with hemoglobin, entering into the cycle described
in Figure 2.
If, in fact, chain mechanisms are operating in the
HbO2-PHZ and MHb-PHZ systems, then one would
expect the ratio of PHZ consumed, compared to the
amount of phenyl attached to heme via reaction M in
Figure 1, to decrease as the concentration of PHZ is
decreased. Decreasing the PHZ concentration while
holding heme concentration constant would lower the
likelihood that PR would abstract hydrogen from PHZ,
thus initiating another cycle ofPHZ destruction, as com-
pared to abstraction of a hydrogen atom from another
donor (reaction U). Indeed this behavior is observed.
Augusto et al. (24) found that when the HbO2 concen-
tration was maintained at 5 x 10-6 M and the concen-
tration of PHZ was varied between 40 x 10-4 M and
1 X 10-4 M, then the ratio of oxygen consumed per
heme modified decreased from 6 to 3.7. Stiochiometric
considerations (one PHZ consumed per 02 consumed)
therefore requires that the amount of PHZ consumed
per heme modified decrease as well. Similar behavior
is observed in the MHb-PHZ system (24).
Another test that can be applied is to check whether
the mechanisms for benzene and heme adduct forma-
tion, outlined in Figures 1 and 2, can account for the
observed stoichiometries relating consumption of oxy-
gen and PHZ and the production of benzene and heme
adduct (24). When the stoichiometric equations are
worked out for the various pathways leading from hemo-
globin and PHZ to formation ofbenzene or heme adduct,
the following equations are obtained: (note that reac-
tions T and U in Fig. 2 are included in these equations.)
CASE 1. HbO2-mediated oxidation ofPHZ, in which
heme is not destroyed, but returned to the form HbO2
at the end of the cycle.
CASE 1A. Reaction proceeds via steps
H-*J-*B-C-E-F-G
or
H -,J ,B ,C ,D -G
PHZ + 02 -- PH + N2 + H202
This is consistent with the findings of Augusto et al.
(24) that for each molecule of PHZ consumed, one mol-
ecule of 02 iS consumed from the surrounding medium
in HbO2- and MHb-mediated oxidations of PHZ.
Other species, generated in the reactions of Figure
1, can enter into the scheme of Figure 2 to undergo
2 PHZ + 2.502 + 2RH + H+
2PH + 1.5H202 + 2N2 + 2[H20] + 2R
CASE 1B. Reaction proceeds via steps
H --+K --*L -*F +G
PHZ + 02 + RH + H+ -, PH + N2 + 2[H20] + R'
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CASE 2: MHb-mediated oxidation of PHZ, in which
heme is not destroyed, but returned to the form ofMHb
at the end of the cycle. Reaction proceeds by steps
A -- B--+ C-* E - F - G-- H--J--+ A'
or
A -i B--* C - D -, G--* H--J--* A'
2 PHZ + 2.502 + 2RH + H+ -*
2PH + 1.5H202 + 2N2 + 2[H20] + 2R
CASE 3. HbO2-mediated oxidation of PHZ, in which
III is a product.
CASE 3A. Reaction proceeds via branch J.
HbO2 + 2 PHZ + 1.502 + RH + H+--
III + PH + 1.5H202 + 2[H20] + R
CASE 3B. Reaction proceeds via branch K.
HbO2 + PHZ + H+ -+ III + 2[H20] + N2
CASE 4. MHb-mediated oxidation of PHZ in which
III is a product. Reaction proceeds by steps
A -+B -+C -* M
MHb + PHZ + 0.502 + 0.5H202 - III + N2 + 2[H20]
Not all of the above pathways display a stoichiometry
that implies that one oxygen is consumed per PHZ ox-
idized. Yet Augusto et al. (24) found that the reactive
processes occurring in both HbO2-PHZ and MHb-PHZ
systems consumed one 02 per PHZ destroyed. How can
this apparent inconsistency be understood? The answer,
of course, is that the overall stoichiometry observed in
reacting hemoglobin-PHZ systems is determined by
the quantitative mix of processes actually occurring in
the system being studied. Some simple examples illus-
trate this point. If, in the HbO2-PHZ system, one de-
structive reaction via the pathway of Case 3A occurred
per nondestructive cycle over one of the pathways de-
scribed by Case 1A, then the resultant observed stoi-
chiometry would be:
HbO2 + 4PHZ + 402 + 2H+ + 3RH-
3PH + III + 4N2 + 3H202 + 4[H20] + 3R-
Thus we would observe that a one-to-one relationship
existed between PHZ and 02 consumption. Iftwo cycles
of the phenyl radical-mediated pathway for PHZ oxi-
dation are included
PHZ + 02 -_ PH + N2 + H202
then the observed overall stoichiometry would be:
HbO2 + 6PHZ + 602 + 2H+ + 3RH-*
5PH + III + 6N2 + 5H202 + 4[H20] + 3R
This stoichiometry, with respect to HbO2, PHZ, 02, and
PH, is that observed by Augusto et al. (24) at high
PHZ/HbO2 ratios. Application of similar reasoning to
combinations of some (but not all) ofthe above pathways
(e.g., Case 1B + Case 3B, Case 2 + Case 4) yields the
same one-to-one relationship between PHZ and oxygen
consumption. Inclusion of the appropriate contribution
of PR-mediated oxidation of PHZ, as above, allows the
observed stoichiometries of benzene formed per heme
modified to be explained. Other mixes of the same re-
actions can lead to nearly the same results. For ex-
ample, there is no a priori reason why the probability
of PHZ entering a reaction pathway leading to heme
destruction should be the same as the probability of its
entry into a cycle where heme is not destroyed. Con-
sider again a HbO2-PHZ system where Case 1A + Case
3A obtains; if the probability of entrance of PHZ into
Case 1A is twice that of entering into Case 3A, then
the resultant observed stoichiometry would require that
6.502 be consumed per 6PHZ used up and 5 benzenes
be produced per heme modified. The value of 1.0802
consumed per PHZ consumed would probably be
rounded off to one to one stoichiometry, considering
experimental error, and the total resultant stoichiom-
etry would be that observed in HbO2-PHZ systems at
high heme/PHZ concentrations (24).
In summary, the total chemistry occurring in hemo-
globin-PHZ systems is probably a complex combination
ofthe reactions of Figure 1, in which PHZ reaction leads
to destruction of heme and generation of PHZ oxidation
products, and the reactions of Figure 2, leading to con-
version ofPHZ oxidation products to benzene and other
substances. The observed stoichiometry reflects the
weighted contributions of these individual reactions to
the total chemistry, rather than a requirement that each
contributing pathway have the same stoichiometry as
the observed overall reaction (e.g., 1:1 stoichiometry
for PHZ and 02 consumption).
The superoxide anion can be produced at three junc-
tures in the reaction schemes displayed in Figures 1 and
2, namely steps E, P, and Q. As 02 does not play a
role in reactions leading to benzene formation, it is likely
that it is destroyed by disproportionation as depicted
by reaction T.
The effects of inhibitors of the rates of formation of
benzene and superoxide in hemoglobin-PHZ systems
can be profitably discussed together. Goldberg and
Stern (15,30) found that both thiocyanate and catalase
almost completely inhibited superoxide formation and
benzene production in the MHb-PHZ system. In the
HbO2-PHZ system, however, these substances only
partially inhibited the production of superoxide (15,30).
Examination of the data taken by Goldberg and Stern
(30) during the initial 3 min of the HbO2-PHZ reaction
suggests that SCN- has some inhibitory effect on ben-
zene formation, though catalase has no significant in-
hibitory effect on the production of this compound.
The effect of catalase on the rate of the MHb-me-
diated production of benzene and superoxide can be
understood if it recalled that this reaction requires a
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buildup of H202, putatively via autoxidation of PHZ in
solution, in order for hemoglobin-catalyzed oxidation to
become rapid. Addition of catalase would increase the
time required for the fast phase of PHZ oxidation to set
in. Indeed, Augusto et al. (24) found that catalase at
390 and 871 units/mL resulted in the lag time in a MHb-
PHZ system increasing from 1.15 min to 1.35 and 1.70
min, respectively. Goldberg and Stern (15,30) used cat-
alase at a concentration of3500 units/mL in their studies
of inhibition of O2- and benzene formation in the MHb-
PHZ system; they also employed about a sevenfold
lower starting PHZ concentration than Augusto et al.
(24). Under these conditions, it is not surprising that
they saw little benzene or superoxide formation during
the 5-min duration of their experiments. The inhibitory
action of SCN- on benzene and 02 production can be
understood in terms of its ability to compete with PHZ
for the peroxidase activity associated with Hb FeIvO.
The experiments of Goldberg and Stern (30) used 80
mM SCN - to compete with PHZ at a concentration of
0.2 mM (in the reaction where benzene was monitored).
Complete diversion of Hb FeIvO to reaction pathways
involving oxidation of SCN- would prevent formation
of the precursors of 02 and PH and hence 02 and PH
themselves.
The effect of SCN-, in causing partial inhibition of
benzene and 02- formation in HbO2-PHZ systems, can
be understood by noting that SCN- would once again
compete with PHZ for Hb FeIvO. However, in contrast
to the MHb-PHZ system, there are several other path-
ways to these products not involving Hb FeIvO acces-
sible to competitive thiocyanate inhibition. One of these
(step J, followed by oxidation ofPHZR as shown in Fig.
2) would lead to formation of benzene and O2 without
accompanying formation of III. The second (steps K, L
and F followed by entrance of P into the cycle of Fig.
2) would also yield PH and superoxide. In this latter
pathway, Hb FeIvO.PHZR might be viewed as a com-
plex in which the ferryl moiety is unavailable to SCN -
because its normal access channel to the heme cavity is
blocked by PHZR.
The partial inhibitory effect of catalase on the rate of
production of 02 can be explained by its effect on the
concentration of MHb-H202, determined in part by the
reactions A and A'. Consumption of H202 by catalase
would lower steady-state concentrations of MHb-H202,
and hence Hb FeIvO, present. This would, in turn,
lower the rate of formation of superoxide via pathways
leading through uncomplexed ferryl hemoglobin. Inhi-
bition would not be complete, as other pathways leading
to O2 formation would not be affected.
It is not clear that an unambiguous interpretation can
be made of the noninhibitory effect of catalase on ben-
zene formation, reported by Goldberg et al. (30); recent
studies have shown that catalase itself reacts with PHZ
to generate benzene as a product (41).
Hydrogen peroxide appears as a product in step A'
in Figure 1 and via disproportionation of O2 in step T
of Figure 2. These two sources would account for the
production of H202 in HbO2-PHZ systems described by
()02 N
HbO2 ' Hb Nt
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FIGURE 3. Proposed mechanistic scheme showing the pathways of
reaction of hemoglobin with phenyldiazene.
Rostorfer and Cormier (29) and Cohen and Hochstein
(14).
Reactions of Phenyidiazene with
Hemoglobin
In this section we will briefly discuss the question of
what happens when PDA is mixed with HbO2 or MHb.
(As discussed above, PDA evidently forms a complex
with the globin portion of deoxyhemoglobin, but does
not react with the heme group to yield modified heme
products.) Since the experimental information about
HbO2-PDA and MHb-PDA systems is very sparse,
compared to the corresponding PHZ systems, the me-
chanistic scheme proposed here (Fig. 3) is necessarily
much more speculative than the mechanisms of Figures
1 and 2. Indeed, it would be considered more predictive
in nature than descriptive. However, based on what is
known about the reactions occuring in hemoglobin-PHZ
systems, the reactions contained within Figure 3 seem
reasonable.
It has been found that the products resulting from
addition of PDA to HbO2 include methemoglobin (33)
and a hemichrome (25,33) with an absorption spectrum
very similar to that of hemoglobin containing III (33).
The destruction of HbO2 was inhibited by catalase or
SOD, while Hb-CO did not undergo reaction. Figure 3
contains a simple scheme that accounts for these results.
Phenyldiazene serves as a one-electron reductant (re-
action V), producing 02 and a HbPDAR complex anal-
ogous to that formed in reaction E of Figure 1. This
complex, as before, collapses to form III via reaction
M. Alternatively the Hb.PDAR complex, as was the
case in Figure 1, can react to form phenyl radical and
Hb. The PR formed could then abstract hydrogen from
available hydrogen donors, including PDA. If PDA
were the donor, then the benzene producing and PR
regenerating cycle, described by reactions R and X,
would be set up. Phenyl radicals, produced by the HbO2-
mediated oxidation of PDA, would be those putatively
involved in initiation of lipid peroxidation reactions in
the cell membrane when erythrocytes are treated with
PDA (33).
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The anaerobic reaction of MHb with PDA, to form a
substance with a characteristic visible absorption spec-
trum, was described by Itano and Robinson (21) in 1961.
The possible nature of this complex has been probed,
or commented on, in a number of studies since that time
(23,25,48). Very recent work, employing NMR spec-
troscopy to study the product of the anaerobic reaction
of metmyoglobin with PDA, has demonstrated that III
is the product in this case (Ortiz de Montellano and Kerr,
unpublished results); this suggests that the same is true
in the MHb-PDA system. This is in accord with the
scheme presented in Figure 3. The scheme also predicts
that Hb could be a product of the anaerobic reaction of
MHb with PDA, if reaction F were competitive with
reaction M. In fact, Itano and Mannen (23) reported
that Hb was formed as a product in the MHb-PDA
reaction, along with the complex that is probably III.
Information about stoichiometry of oxygen and PDA
consumption and amount of modified heme produced per
PDA consumed, for either the HbO2-PDA or MHb-
PDA system, is unavailable. Thus little can be said,
beyond the above presentation, concerning the viability
of the mechanistic scheme proposed in Figure 3. Ob-
viously this is an area where experimental work, to
obtain quantitative information about stoichiometry and
rates of product formation, would be welcome.
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